Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer

Sharon J. Parish, Professor of Medicine in Clinical Psychiatry and Professor of Clinical Medicine at Weill Cornell Medical College; Director of Medical Services at New York Presbyterian Hospital/Westchester Division

“For women navigating life after breast cancer, this need can be particularly profound. While advances in cancer care have improved outcomes for many patients, survivors may continue to face significant challenges related to menopause, sexual function, intimacy, and overall quality of life. For some women, a history of hormone-sensitive cancer can further complicate treatment decisions, underscoring the importance of advancing research into nonhormonal approaches. Events like this are important for raising awareness of these challenges and advancing conversations around the unmet needs in women’s health. I am pleased to be speaking at this event and contributing to these important discussions.”

Sabrina Martucci Johnson, President and Chief Executive Officer of Daré Bioscience

“Surviving breast cancer should not mean having to accept a diminished quality of life or abandon an important part of what makes many women feel whole.”

Sabrina Martucci Johnson, President and Chief Executive Officer of Daré Bioscience

“Women's menopause and sexual health concerns have too often been overlooked or undertreated, including the particular concerns of breast cancer survivors. By supporting clinicians and researchers advancing the conversation around menopause after breast cancer, we are reinforcing our commitment to ensuring women's sexual health and quality of life are recognized as essential components of healthcare.”

Sabrina Martucci Johnson, President and Chief Executive Officer of Daré Bioscience

“Nonhormonal innovation is important because there is no single treatment approach that meets every woman's needs.”

Sabrina Martucci Johnson, President and Chief Executive Officer of Daré Bioscience

“We are advancing science-based solutions across contraception, menopause, sexual health, and other areas of unmet need, including for women who have historically had limited options.”